These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25477335)

  • 1. H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis.
    Wu PC; Lu JW; Yang JY; Lin IH; Ou DL; Lin YH; Chou KH; Huang WF; Wang WP; Huang YL; Hsu C; Lin LI; Lin YM; Shen CK; Tzeng TY
    Cancer Res; 2014 Dec; 74(24):7333-43. PubMed ID: 25477335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation.
    Lohmann F; Loureiro J; Su H; Fang Q; Lei H; Lewis T; Yang Y; Labow M; Li E; Chen T; Kadam S
    Stem Cells; 2010 Feb; 28(2):201-12. PubMed ID: 20014010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory circuitry comprising TP53,
    Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of SETDB1 as a therapeutic target.
    Karanth AV; Maniswami RR; Prashanth S; Govindaraj H; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
    Expert Opin Ther Targets; 2017 Mar; 21(3):319-331. PubMed ID: 28076698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis.
    Tang YN; Ding WQ; Guo XJ; Yuan XW; Wang DM; Song JG
    Nat Commun; 2015 Sep; 6():8230. PubMed ID: 26354229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
    Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
    BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
    Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
    Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells.
    Lee JK; Kim KC
    Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex.
    Fritsch L; Robin P; Mathieu JR; Souidi M; Hinaux H; Rougeulle C; Harel-Bellan A; Ameyar-Zazoua M; Ait-Si-Ali S
    Mol Cell; 2010 Jan; 37(1):46-56. PubMed ID: 20129054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis.
    Kim K; Ryu TY; Jung E; Han TS; Lee J; Kim SK; Roh YN; Lee MS; Jung CR; Lim JH; Hamamoto R; Lee HW; Hur K; Son MY; Kim DS; Cho HS
    Exp Mol Med; 2023 May; 55(5):952-964. PubMed ID: 37121971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex.
    Timms RT; Tchasovnikarova IA; Antrobus R; Dougan G; Lehner PJ
    Cell Rep; 2016 Oct; 17(3):653-659. PubMed ID: 27732843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.
    Schultz DC; Ayyanathan K; Negorev D; Maul GG; Rauscher FJ
    Genes Dev; 2002 Apr; 16(8):919-32. PubMed ID: 11959841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
    Ueshima S; Fang J
    Oncogene; 2022 Jun; 41(24):3370-3380. PubMed ID: 35546351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
    Rodriguez-Paredes M; Martinez de Paz A; Simó-Riudalbas L; Sayols S; Moutinho C; Moran S; Villanueva A; Vázquez-Cedeira M; Lazo PA; Carneiro F; Moura CS; Vieira J; Teixeira MR; Esteller M
    Oncogene; 2014 May; 33(21):2807-13. PubMed ID: 23770855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth.
    Zhang YX; Yan YF; Liu YM; Li YJ; Zhang HH; Pang M; Hu JX; Zhao W; Xie N; Zhou L; Wang PY; Xie SY
    Cell Death Dis; 2016 Dec; 7(12):e2528. PubMed ID: 28005074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
    Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
    J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of the epigenetic regulator SETDB1 in liver carcinogenesis-more than one way to skin a cat.
    Longerich T
    Chin Clin Oncol; 2016 Dec; 5(6):72. PubMed ID: 27164857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.